← Krystal Biotech, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $1.9m | $49.6m | $103.7m | $187.5m | $268.3m | $341.2m | $161.9m | $358.3m | $344.9m | $496.3m | |
| Prepaid Expense and Other Assets, Current | — | — | $889k | $2.2m | $3.8m | $4.2m | $4.6m | $6.7m | $13.3m | $14.9m | |
| Cash, Cash Equivalents, and Short-term Investments | — | — | — | $193.7m | $271.3m | $438.1m | — | $532.2m | $597.5m | $827.8m | |
| Inventory, Net | — | — | — | — | — | — | $0 | $7.0m | $26.5m | $40.5m | |
| Assets, Current | $2.2m | $49.9m | $112.7m | $195.9m | $275.1m | $442.3m | $383.8m | $587.9m | $742.0m | $1.0b | |
| Property, Plant and Equipment, Net | $13k | $200k | $3.0m | $8.5m | $30.9m | $112.4m | $161.7m | $161.2m | $155.2m | $150.8m | |
| Operating Lease, Right-of-Use Asset | — | — | — | $2.7m | $3.3m | $7.2m | $8.0m | $7.0m | $6.3m | $7.2m | |
| Other Assets, Noncurrent | — | — | $452k | $1.5m | $1.6m | $74k | $324k | $263k | $231k | $287k | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | — | — | — | — | — | — | $0 | $42.0m | $104.7m | $127.4m | |
| Assets | $2.2m | $50.1m | $116.1m | $209.0m | $310.8m | $626.3m | $558.5m | $818.4m | $1.1b | $1.3b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $480k | $5.1m | $1.0m | $1.6m | $1.5m | $1.2m | $1.8m | |
| Accounts Payable, Current | $42k | $193k | $888k | $724k | $2.1m | $8.4m | $4.0m | $4.1m | $5.0m | $3.2m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $2.8m | $3.3m | $7.0m | $7.4m | $6.6m | $6.0m | $7.6m | |
| Liabilities, Current | $43k | $640k | $2.6m | $3.3m | $15.5m | $25.7m | $28.8m | $33.1m | $102.0m | $102.9m | |
| Other Liabilities, Noncurrent | — | — | $294k | — | — | — | — | — | $1.4m | $3.7m | |
| Deferred Tax Liabilities, Net | $0 | — | $145k | $1.1m | $4.3m | $2.7m | $3.3m | $14.6m | $15.0m | $15.5m | |
| Liabilities | $1.9m | $640k | $2.9m | $6.1m | $18.8m | $32.7m | $36.2m | $39.7m | $109.5m | $114.2m | |
| Stockholders’ equity: | |||||||||||
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Common Stock, Value, Issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Additional Paid in Capital | $33k | $58.5m | $133.2m | $242.0m | $363.3m | $734.5m | $803.7m | $1.0b | $1.1b | $1.2b | |
| Retained Earnings (Accumulated Deficit) | ($1.1m) | ($9.1m) | ($20.0m) | ($39.0m) | ($71.2m) | ($140.8m) | ($280.8m) | ($269.8m) | ($180.7m) | $24.2m | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | — | — | $2k | $10k | $6k | ($163k) | ($728k) | $638k | ($190k) | $1.1m | |
| Stockholders' Equity Attributable to Parent | $289k | $49.5m | $113.2m | $202.9m | $292.1m | $593.6m | $522.2m | $778.6m | $946.4m | $1.2b | |
| Liabilities and Equity | $2.2m | $50.1m | $116.1m | $209.0m | $310.8m | $626.3m | $558.5m | $818.4m | $1.1b | $1.3b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.